Representatives from the pharmaceutical industry meet regularly with AWTTC and monitor the implementation of AWMSG's Therapeutic Development Assessment (TDA) process for AWMSG and the pharmaceutical industry.
These informal meetings, between representatives of the Association of the British Pharmaceutical Industry (ABPI) Wales Value Group and AWTTC, facilitate two-way communication between industry and AWTTC to inform process or improve methodology in Wales and to share experiences of industry engagement with other health technology assessment (HTA) organisations.
For more information please contact us.